ArticleBritish journal of cancer2021

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.

Kun-Han Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.